Fusion Family Wealth’s Chemours CC Stock Holding History

Fusion Family Wealth’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20	Closed	-$1K	–	291
2017 Q3	$1K	Buy	+20	New	+$944	﹤0.01%	210

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fusion Family Wealth's CC Position: Q4 2017 in Review

Fusion Family Wealth sold out of Chemours (CC) in Q4 2017, closing a stake of 20 shares — an estimated $1K sold.

Fusion Family Wealth first reported a position in CC in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 537 funds tracked by Wall St. Rank hold CC as of Q4 2017.

Fusion Family Wealth reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
Fusion Family Wealth sold 20 Chemours shares in Q4 2017, an estimated $1K.
Fusion Family Wealth first reported a position in Chemours in Q3 2017 and held it in 1 quarter.
Fusion Family Wealth's Chemours position peaked at $1K in Q3 2017.
537 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Fusion Family Wealth's 13F filing for Q4 2017, filed 6 Feb 2018.